Literature DB >> 22771050

Digestive and physiologic effects of a wheat bran extract, arabino-xylan-oligosaccharide, in breakfast cereal.

Kevin C Maki1, Glenn R Gibson, Robin S Dickmann, Cyril W C Kendall, C-Y Oliver Chen, Adele Costabile, Elena M Comelli, Diane L McKay, Nelson G Almeida, David Jenkins, Gordon A Zello, Jeffrey B Blumberg.   

Abstract

OBJECTIVE: We assessed whether a wheat bran extract containing arabino-xylan-oligosaccharide (AXOS) elicited a prebiotic effect and influenced other physiologic parameters when consumed in ready-to-eat cereal at two dose levels.
METHODS: This double-blind, randomized, controlled, crossover trial evaluated the effects of consuming AXOS at 0 (control), 2.2, or 4.8 g/d as part of ready-to-eat cereal for 3 wk in 55 healthy men and women. Fecal microbial levels, postprandial serum ferulic acid concentrations, and other physiologic parameters were assessed at the beginning and end of each condition.
RESULTS: The median bifidobacteria content of stool samples (log₁₀/grams of dry weight [DW]) was found to be higher in the subjects consuming the 4.8-g/d dose (10.03) than in those consuming 2.2 g/d (9.93) and control (9.84, P < 0.001). No significant changes in the populations of other fecal microbes were observed, indicating a selective increase in fecal bifidobacteria. Postprandial ferulic acid was measured at 120 min at the start and end of each 3-wk treatment period in subjects at least 50 y old (n = 37) and increased in a dose-dependent manner (end-of-treatment values 0.007, 0.050, and 0.069 μg/mL for the control, AXOS 2.2 g/d, and AXOS 4.8 g/d conditions, respectively, P for trend < 0.001).
CONCLUSION: These results indicate that AXOS has prebiotic properties, selectively increasing fecal bifidobacteria, and increases postprandial ferulic acid concentrations in a dose-dependent manner in healthy men and women.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22771050     DOI: 10.1016/j.nut.2012.02.010

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  21 in total

1.  Mutual Cross-Feeding Interactions between Bifidobacterium longum subsp. longum NCC2705 and Eubacterium rectale ATCC 33656 Explain the Bifidogenic and Butyrogenic Effects of Arabinoxylan Oligosaccharides.

Authors:  Audrey Rivière; Mérilie Gagnon; Stefan Weckx; Denis Roy; Luc De Vuyst
Journal:  Appl Environ Microbiol       Date:  2015-08-28       Impact factor: 4.792

2.  Obese ZDF rats fermented resistant starch with effects on gut microbiota but no reduction in abdominal fat.

Authors:  Felicia Goldsmith; Justin Guice; Ryan Page; David A Welsh; Christopher M Taylor; Eugene E Blanchard; Meng Luo; Anne M Raggio; Rhett W Stout; Diana Carvajal-Aldaz; Amanda Gaither; Christine Pelkman; Jianping Ye; Roy J Martin; James Geaghan; Holiday A Durham; Diana Coulon; Michael J Keenan
Journal:  Mol Nutr Food Res       Date:  2016-08-11       Impact factor: 5.914

3.  Complementary Mechanisms for Degradation of Inulin-Type Fructans and Arabinoxylan Oligosaccharides among Bifidobacterial Strains Suggest Bacterial Cooperation.

Authors:  Audrey Rivière; Marija Selak; Annelies Geirnaert; Pieter Van den Abbeele; Luc De Vuyst
Journal:  Appl Environ Microbiol       Date:  2018-04-16       Impact factor: 4.792

4.  Effects of wheat bran extract rich in arabinoxylan oligosaccharides and resistant starch on overnight glucose tolerance and markers of gut fermentation in healthy young adults.

Authors:  Elin V Johansson Boll; Linda M N K Ekström; Christophe M Courtin; Jan A Delcour; Anne C Nilsson; Inger M E Björck; Elin M Östman
Journal:  Eur J Nutr       Date:  2015-07-14       Impact factor: 5.614

Review 5.  Role of resistant starch in improving gut health, adiposity, and insulin resistance.

Authors:  Michael J Keenan; June Zhou; Maren Hegsted; Christine Pelkman; Holiday A Durham; Diana B Coulon; Roy J Martin
Journal:  Adv Nutr       Date:  2015-03-13       Impact factor: 8.701

Review 6.  Gut microorganisms as promising targets for the management of type 2 diabetes.

Authors:  Nathalie M Delzenne; Patrice D Cani; Amandine Everard; Audrey M Neyrinck; Laure B Bindels
Journal:  Diabetologia       Date:  2015-07-31       Impact factor: 10.122

7.  Tolerance and the effect of high doses of wheat bran extract, containing arabinoxylan-oligosaccharides, and oligofructose on faecal output: a double-blind, randomised, placebo-controlled, cross-over trial.

Authors:  Isabelle E J A François; Olivier Lescroart; Wim S Veraverbeke; Karen Windey; Kristin Verbeke; Willem F Broekaert
Journal:  J Nutr Sci       Date:  2014-10-20

8.  Effects of Low Level Water-soluble Pentosans, Alkaline-extractable Pentosans, and Xylanase on the Growth and Development of Broiler Chicks.

Authors:  Q K Sheng; L Q Yang; H B Zhao; X L Wang; K Wang
Journal:  Asian-Australas J Anim Sci       Date:  2013-09       Impact factor: 2.509

9.  Enzymatically-Processed Wheat Bran Enhances Macrophage Activity and Has in Vivo Anti-Inflammatory Effects in Mice.

Authors:  Hee Kang; Mi-Gi Lee; Jae-Kang Lee; Yong-Hyun Choi; Yong-Seok Choi
Journal:  Nutrients       Date:  2016-04-01       Impact factor: 5.717

Review 10.  Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut.

Authors:  Audrey Rivière; Marija Selak; David Lantin; Frédéric Leroy; Luc De Vuyst
Journal:  Front Microbiol       Date:  2016-06-28       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.